Table 3.
Strategies for the prevention of sudden cardiac death and future research directions.
Risk Factor | Strategies to Prevent Sudden Cardiac Death | Gaps in Knowledge & Future Research Areas |
---|---|---|
Potassium (K) accumulation and removal | Frequent serum K assessment and dialysate K adjustment. Avoid dialysate K <2 meq/L. Oral K binding resins. |
Optimal dialysate-to-serum-K gradient. Safety and effectiveness of dialysate K profiling. |
Bicarbonate homeostasis | Avoidance of low dialysate bicarbonate. Do not account for other perceived sources of base/buffer (e.g., acetate). Avoid using the wrong concept of “total buffer” |
Optimal dialysate bicarbonate concentration. Better education and understanding of the role of acetate in acid concentrate, which should not be added to bicarbonate in the dialysate |
Calcium (Ca) homeostasis | Avoid low dialysate Ca <2.5 meq/L. Avoid high dialysate-to-serum Ca gradient. Use vitamin D analogs, Ca-based binders, calcimimetics to optimize serum Ca. |
Optimal dialysate-to-serum-Ca gradient. |
Magnesium (Mg) homeostasis | Avoid low dialysate Mg. Titrating dialysate Mg in Mg-losing states (i.e., GI losses/diarrhea, PPI use, malnutrition). |
Optimal dialysate Mg concentration. |
Fluid accumulation and removal | Reduce salt and fluid intake. Diuretics among pts with RKF. Longer HD time. More frequent HD sessions. Nocturnal HD. Smaller dialysate-to-Na-gradient. Avoid intradialytic hypotension. |
Practical bedside tools/devices to ascertain estimated dry weight and volume status. Optimal UFR for specific patient populations. Role of dialysate cooling. |
Abbreviations: K, potassium; Ca, calcium; Mg, magnesium; GI, gastrointestinal; PPI, proton pump inhibitor; RKF, residual kidney function; HD, hemodialysis; Na, sodium; UFR, ultrafiltration rate.